the CFO of Interbug Biotech has been analyzing the company's capital structure. It is 50% equity using retained earnings. Currently the company uses retained earning for common equity with a cost of 10%. When the amount of retained earnings exceeds $5 million the company will need to issue new common equity. At what level of capital will the retained earning be used up and require the company to issue new equity